Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. Êèñòà ãàéìîðîâîé ïàçóõè - âûáîð ìåòîäà îïåðàöèè
    îò Yanabell â ðàçäåëå Áîëåçíè óõà, ãîðëà è íîñà
    Îòâåòîâ: 1
    : 21.09.2004, 18:52
  2. Âûáîð ìåòîäà ëå÷åíèÿ áåñïëîäèÿ
    îò Tahni â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 2
    : 01.09.2004, 19:30
  3. Âûáîð ìåòîäà ëå÷åíèÿ
    îò Evelina â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 17
    : 01.09.2004, 19:30
  4. Îòâåòîâ: 16
    : 01.09.2004, 19:30
  5. âûáîð ìåòîäà êîíòðàöåïöèè, íîâèíåò
    îò Ýëëèíà â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 12
    : 01.09.2004, 19:30
  1. Evelina
    #1
    ×èòàòåëü Íåäóã.Ðó
    Áîðèñ, ïîìîãèòå!!!

    Ó ìóæà âîò òàê âûãëÿäèò ñïåðìîãðàììà:

    îáúåì 4,6 ìë âðåìÿ ðàçæèææåíèÿ 30 ìèí

    êîíöåíòðàöèÿ 7 ìëí â 1 ìë

    àêòèâíîïîäâèæíûõ ñ áûñòðîé ïðîãðåññèåé 24%

    ñ ìåäëåííîé 43%

    ìàëîïîäâèæíûõ 19%

    íåïîäâèæíûõ 14%

    % ïîäâèæíûõ À+Â=67%

    ïàòîëîãèÿ ãîëîâêè 55%

    ïàòîëîãèÿ øåéêè 30%

    ïàòîëîãèÿ õâîñòà 15%

    ìîðôîëîãè÷åñêèé èíäåêñ ôåðòèëüíîñòè Êðþãåðà 4%



    ×òî áû âû ðåêîìåíäîâàëè ïðè òàêîé ñïåðìîãðàììå ÝÊÎ èëè ÝÊÎ\ÝÊÑÈ?

    Çàðàíåå ñïàñèáî.

  2. Zhivov
    #2
    ×èòàòåëü Íåäóã.Ðó
    Äîðîãîé Áîðèñ,

    À Âû òàê âîò âñåãäà ñïåøèòå ðåêîìåíäîâàòü ICSI äàæå íå ïîèíòåðåñîâàâøèñü òåì ôàêòîì, ïîòåíöèàëüíî êóðàáåëüíà ëè ïðè÷èíà ìóæñêîãî ôàêòîðà èíôåðòèëüíîñòè ó äàííîé ïàðû? Êîíå÷íî æå âûáîð âñåãäà çà ïàöèåíòàìè: ïûòàòüñÿ ëè âûëå÷èòü áåñïëîäèå è ïîëó÷èòü åñòåñòâåííóþ áåðåìåííîñòü èëè ïðèáåãíóòü ê âñïîìîãàòåëüíûì ðåïðîäóêòèâíûì òåõíîëîãèÿì ÷óòü ëè íè ïðè ïåðâîì îáðàùåíèè ê âðà÷ó (ýòî íå îòíîñèòñÿ ê Ýâåëèíå). Íî ìíå ïðåäñòàâëÿåòñÿ, ÷òî åñëè åñòü âîçìîæíîñòü ïîëó÷èòü åñòåñòâåííóþ áåðåìåííîñòü, îíà äîëæíà áûòü èñïîëüçîâàíà. Ñ óâàæåíèåì.

  3. Evelina
    #3
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé!

    ß âñå-òàêè õîòåëà óçíàòü, ÷òî æå ðåêîìåíäóåòñÿ èìåííî ñ òàêèìè ðåçóëüòàòàìè è ïîëó÷èëà îòâåò. À íàñ÷åò ëå÷åíèÿ âû ïðàâû. Èìåííî ïîýòîìó ìû êîíñóëüòèðîâàëèñü ïî ýòîìó âîïðîñó ñ âàìè, êàê ñî ñïåöèàëèñòîì â ýòîé îáëàñòè. Ìû îáäóìûâàåì ðåøåíèå ïî ïîâîäó îïåðàöèè è ïðîõîäèì åùå îáñëåäîâàíèÿ (ÓÇÈ è ò.ä.).

    Áîðèñ, è âñå-òàêè åùå âîïðîñ: åñòü ëè õîòü êàêîé-òî øàíñ ñ òàêîé ñïåðìîãðàììîé íà èíñåìèíàöèþ?

    Ïðîñòî õî÷åòñÿ çíàòü âñå è ïîòîì äåëàòü îêîí÷àòåëüíûé âûáîð.

    Ñ óâàæåíèåì ê äîêòîðàì. Ýâåëèíà.

  4. boris
    #4
    ×èòàòåëü Íåäóã.Ðó
    Ïî ïîâîäó ïîêàçàíèé äëÿ ïðîâåäåíèÿ èñêóññòâåííîé èíñåìèíàöèè ÿ òîëüêî ÷òî îïóáëèêîâàë ñîîáùåíèå çäåñü (http://forums./showthread.php3?threadid=3723)

  5. boris
    #5
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!



    À Âû òàê âîò âñåãäà ñïåøèòå ðåêîìåíäîâàòü ICSI äàæå íå ïîèíòåðåñîâàâøèñü òåì ôàêòîì, ïîòåíöèàëüíî êóðàáåëüíà ëè ïðè÷èíà ìóæñêîãî ôàêòîðà èíôåðòèëüíîñòè ó äàííîé ïàðû?

    ß ñ Âàìè ïîëíîñòüþ ñîãëàñåí, ÷òî ïðèìåíåíèå ìåòîäîâ âñïîìîãàòåëüíîé ðåïðîäóêöèè ÿâëÿåòñÿ äàëåêî íå åäèíñòâåííûì ìåòîäîì (â íàøåì ñëó÷àå íå ëå÷åíèÿ, à ïðåîäîëåíèÿ) ìóæñêîãî áåñïëîäèÿ. Ìîé ëè÷íûé îïûò îáùåíèÿ ñ ïàöèåíòàìè ñ òÿæåëûìè íàðóøåíèÿìè ñïåðìàòîãåíåçà (à ïðèâåäåííûå äàííûå î 4% íîðìàëüíûõ ôîðì ïî Êðþãåðó ãîâîðèò î òÿæåëîé òåðàòîçîîñïåðìèè) ïîçâîëÿåò ìíå ðåêîìåíäîâàòü â äàííîé ñèòóàöèè èìåííî ïðèìåíåíèå ìåòîäîâ âñïîìîãàòåëüíîé ðåïðîäóêöèè (ICSI). Ïîäàâëÿþùåå áîëüøèíñòâî ïàöèåíòîâ, âïåðâûå îáðàòèâøèåñÿ â íàø öåíòð ñ ïîäîáíûìè íàðóøåíèÿìè è ïðîâîäèâøèìè ïðåäâàðèòåëüíóþ êîíñåðâàòèâíóþ òåðàïèþ, âîçâðàùàëèñü äëÿ ïðîâåäåíèÿ ICSI ñ ðåçóëüòàòàìè íå îòëè÷àþùèìèñÿ îò ïðåäøåñòâóþùèõ èëè õóäøèìè.

    Íî ìíå ïðåäñòàâëÿåòñÿ, ÷òî åñëè åñòü âîçìîæíîñòü ïîëó÷èòü åñòåñòâåííóþ áåðåìåííîñòü, îíà äîëæíà áûòü èñïîëüçîâàíà.

    ß òîëëüêî ìîãó ïîääåðæàòü Âàøå âûñêàçûâàíèå è öåëèêîì è ïîëíîñòüþ ñ ýòèì ñîãëàñåí. ... íî ýòî äðóãèå ïàöèåíòû :



    Ñîâñåì äðóãàÿ êàòåãîðèÿ ïàöèåíòîâ ñ ò.í. ñóáôåðòèëüíîé ñïåðìîé (ëåãêèå ôîðìû àñòåíî- îëèãèçîîñïåðìè). Çäåñü ÿ öåëèêîì çà ïðîâåäåíèå êîíñåðâàòèâíîé òåðàïèè áåñïëîäèÿ

  6. Zhivov
    #6
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Áîðèñ Àëåêñàíäðîâè÷,

    Âû íå îáðàòèëè âíèìàíèå íà òî, ÷òî ÿ ãîâîðþ î êîððåãèðóåìûõ ôîðìàõ ìóæñêîé èíôåðòèëüíîñòè.  äàííîì ñëó÷àå ðå÷ü èäåò î òîì, ÷òî ó ñóïðóãà Ýâåëèíû èìååòñÿ âàðèêîöåëå - íàèáîëåå ðàñïðîñòðàíåííàÿ õèðóðãè÷åñêè êîððåãèðóåìàÿ ïðè÷èíà ìóæñêîãî áåñïëîäèÿ (åãî ðàñïðîñòðàíåííîñòü ó ìóæ÷èí ñ ïåðâè÷íûì áåñïëîäèåì ñîñòàâëÿåò 35-40%, ñ âòîðè÷íûì 70-80%). Èçâåñòíî, ÷òî ïîñëå àäåêâàòíîé õèðóðãè÷åñêîé êîððåêöèè øàíñ íîðìàëüíîé áåðåìåííîñòè ó ïàðòíåðø òàêèõ ìóæ÷èí óâåëè÷èâàåòñÿ íà 55-65%.  äàííîì ñëó÷àå ïàöèåíò óæå ðàíåå áûë ïðîîïåðèðîâàí, íî ó íåãî íàñòóïèë ðåöèäèâ. ×òî íàì ìåøàåò óñòðàíèòü âàðèêîöåëå è ïîíàáëþäàòü çà íèì â òå÷åíèå ãîäà ñ ðåãóëÿðíûì êîíòðîëåì ñïåðìîãðàììû. Îïÿòü æå åñëè íå óñòðàíèòü âàðèêîöåëå, êà÷åñòâî ñïåðìû áóäåò è äàëüøå ïðîãðåññèâíî óõóäøàòüñÿ, ÷òî åùå áîëüøå áóäåò ñíèæàòü øàíñû íà íîðìàëüíóþ áåðåìåííîñòü ïðè ëþáîì ñïîñîáå åå äîñòèæåíèÿ.



    ×òî êàñàåòñÿ êîíñåðâàòèâíîãî ëå÷åíèÿ áåñïëîäíûõ ìóæ÷èí, òî îíî ÷àùå âñåãî áûâàåò ýìïèðè÷åñêèì, íå íàïðàâëåíî íà êîððåêöèþ êàêîé ëèáî èçâåñòíîé è âûÿâëåííîé åãî ïðè÷èíû è ÷àùå âñåãî áåñïîëåçíî, â ÷åì ÿ ñ âàìè àáñîëþòíî ñîãëàñåí. Åñëè áû ó äàííîãî ïàöèåíòà íå áûëî áû âàðèêîöåëå èëè êàêîé ëèáî åùå õèðóðãè÷åñêè êîððåãèðóåìîé ïðè÷èíû ìóæñêîé èíôåðòèëüíîñòè, ÿ áû êàê è Âû ðåêîìåíäîâàë áû ýòîé ïàðå ICSI. Íî â äàííîì ñëó÷àå åñòü íàä ÷åì ïîðàáîòàòü è óðîëîãàì. Ñ óâàæåíèåì

  7. boris
    #7
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!



    Íàñêîëüêî ìíå ñòàëî ïîíÿòíî, Âû ëè÷íî çíàêîìû ñ ïàöèåíòîì è âëàäååòå áîëüøåé, íåæåëè ÿ, èíôîðìàöèåé.

    Âîçìîæíà íàøà î÷íàÿ âñòðå÷à ñ ïàöèåíòîì èçìåíèëà áû ìîå ðåøåíèå.  ðàìêàõ æå ôîðóìà ÿ ìîãó äàòü òîëüêî ñàìûå îáùèå ðåêîìåíäàöèè è âûñêàçàòü ìîè ëè÷íûå âçãëÿäû íà ïðîáëåìó, êîòîðûå ìîãóò íå ñîâïàäàòü ñ ìíåíèåì äðóãèõ ñïåöèàëèñòîâ, à ìîãóò áûòü è íå âåðíû. ß ïîëàãàþ, ÷òî ðåêîìåíäàöèè ïîëó÷åííûå â ðàìêàõ ôîðóìà (à ñòàðàþñü ýòî âñåãäà ïîä÷åðêèâàòü) íå ìîãóò çàìåíèòü î÷íîãî êîíòàêòà è íå ìîãóò ðàññìàòðèâàòüñÿ êàê îêîí÷àòåëüíîå çàêëþ÷åíèå.

     äàííîì ñëó÷àå, ó÷èòûâàÿ îòñóòñòâèå ýôôåêòà îò ïðîâåäåííîé òåðàïèè (ê ñîæàëåíèþ ÿ íå çíàþ àíàìíåñòè÷åñêèõ äàííûõ ñóïðóãè), ïîñëå î÷íîãî çíàêîìñòâà, ÿ ñêîðåå âñåãî íå ñòàë áû ðåêîìåíäîâàòü ïîâòîðíîãî îïåðàòèâíîãî âìåøàòåëüñòâà.



    Ñ óâàæåíèåì

    Á.Êàìåíåöêèé

  8. Zhivov
    #8
    ×èòàòåëü Íåäóã.Ðó
    Èíûìè ñëîâàìè Âû ñ÷èòàåòå, Áîðèñ Àëåêñàíäðîâè÷, ÷òî ïðîâåäåííàÿ îïåðàöèÿ ïî ïîâîäó âàðèêîöåëå, êîòîðàÿ äàëà ðåöèäèâ è åñòü ëå÷åíèå, êîòîðîå íå äàëî ðåçóëüòàòà? ß âñå æå äóìàþ, ÷òî åñëè äàííàÿ îïåðàöèÿ äàëà ðåöèäèâ çíà÷èò åå ëå÷åáíîãî ýôôåêòà ïðîñòî íå áûëî. Ìîæåò áûòü ñòîèò ïîïðîáîâàòü ñäåëàòü îïåðàöèþ ëó÷øå è ïîñìîòðåòü íà ëå÷åáíûé ýôôåêò êîãäà åãî äåéñòâèòåëüíî åñòü îò ÷åãî îæèäàòü? Åñëè Âû íå ñîãëàñíû, òî ìíå èíòåðåñíî ïî÷åìó?



    P.S. Ñ ýòîé ïàðîé ÿ çíàêîì ïðîñòî èç îáùåíèÿ íà ôîðóìå.

  9. boris
    #9
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!



    ß âñå æå äóìàþ, ÷òî åñëè äàííàÿ îïåðàöèÿ äàëà ðåöèäèâ çíà÷èò åå ëå÷åáíîãî ýôôåêòà ïðîñòî íå áûëî.

    ... èëè áûëè ïîçèòèâíûå èçìåíåíèÿ â êà÷åñòâå ñïåðìû, êîòîðûå òåì íå ìåíåå íå ïðèâåëè ê íàñòóïëåíèþ áåðåìåííîñòè. Íàñêîëüêî ìíå ïîíÿòíî, îñíîâíàÿ öåëü ñóïðóæåñêîé ïàðû ýòî áåðåìåííîñòü. Ñëîæíî ïðåäñòàâèòü, ÷òî æåíùèíà èìåþùàÿ äëèòåëüíûé àíàìíåç áåñïëîäèÿ àáñîëþòíî çäîðîâà (ÿ èìåþ ââèäó åå ðåïðîäóêòèâíóþ ôóíêöèþ). Æåëàíèå æå äîâåñòè ïîêàçàòåëè ñïåðìîãðàììû ìóæà äî íîðìàëüíûõ ìîãóò òîëüêî ïðèâåòñòâîâàòüñÿ (îñîáåííî åñëè åãî ðàññìàòðèâàòü âíå áåñïëîäíîãî áðàêà è ñ ïåðñïåêòèâîé ñìåíû ïîëîâîãî ïàðòíåðà/æåíû).



    Èçâåñòíî, ÷òî ïîñëå àäåêâàòíîé õèðóðãè÷åñêîé êîððåêöèè øàíñ íîðìàëüíîé áåðåìåííîñòè ó ïàðòíåðø òàêèõ ìóæ÷èí óâåëè÷èâàåòñÿ íà 55-65%.

    Çäåñü ìíå íå ñîâñåì ïîíÿòíà ñòàòèñòè÷åñêàÿ âåëè÷èíà, âîçìîæíî èñïîëüçóåìàÿ â ëèòåðàòóðå, êàê øàíñ íîðìàëüíîé áåðåìåííîñòè . Êàêèì îáðàçîì ýòî âîçìîæíî îöåíèòü. Ïî ìîèì ïðåäñòàâëåíèÿì áåðåìåííîñòü ëèáî íàñòóïàåò, ëèáî íå íàñòóïàåò, à øàíñ åå íàñòóïëåíèÿ ñóùåñòâóåò äàæå ó ìóæ÷èí ñ òÿæåëîé òåðàòîçîîñïåðìèåé. Âåäü äàæå äàííûå ðóêîâîäñòâà ÂÎÇ ïî ëàáîðàòîðíîìó èññëåäîâàíèþ ýÿêóëÿòà ÷åëîâåêà ïðè îïèñàíèè íîðìîñïåðìèè â ãðàôå ìîðôîëîãèÿ îãðàíè÷èâàþòñÿ äîâîëüíî ðàñïëûâ÷àòîé ôîðìóëèðîâêîé "ñíèæåíèå ÷èñëà ìîðôîëîãè÷åñêè íîðìàëüíûõ ñïåðìàòîçîèäîâ íèæå 15%, àññîöèèðóåòñÿ ñî ñíèæåíèåì ÷àñòîòû îïëîäîòâîðåíèÿ in vitro" è íè ñëîâà îá "in vivo".

    Êðîìå òîãî, åñëè Âû ïîìíèòå, ïàöèåíòêà â íà÷àëå ýòîé äèñêóññèè çàäàëà î÷åíü êîíêðåòíûé âîïðîñ êàñàþùèéñÿ âûáîðà ìåæäó ÝÊÎ èëè ÈÊÑÈ: ×òî áû âû ðåêîìåíäîâàëè ïðè òàêîé ñïåðìîãðàììå ÝÊÎ èëè ÝÊÎ\ÝÊÑÈ? è â ðåçóëüòàòå ïîëó÷èëà ñîâåðøåííî êîíêðåòíûé îòâåò: Òîëüêî ÈÊÑÈ.

    Åùå ðàç õî÷ó ïîä÷åðêíóòü, ÷òî ìû ìîæåì òîëüêî ðåêîìåíäîâàòü ïàöèåíòêå òîò èëè èíîé ñïîñîá ðåøåíèÿ ïðîáëåìû (â äàííîé ñèòóàöèè îñíîâíàÿ çàäà÷à ýòî áåðåìåííîñòü). Íó à âûáîð (íà îñíîâàíèè ïîëó÷åííîé èíôîðìàöèè, â òîì ÷èñëå ïîëó÷åííîé è íà ýòîì ôîðóìå) òîëüêî çà ïàöèåíòîì.



    Ñ óâàæåíèåì

    Á.Êàìåíåöêèé

  10. Zhivov
    #10
    ×èòàòåëü Íåäóã.Ðó
    Áîðèñ Àëåêñàíäðîâè÷,

    Ýòî ÷àñòü ïîñòîÿííîãî ñïîðà î òîì, êîãäà íàäî ïåðåõîäèòü ê ICSI. Ñåé÷àñ ñêàæåì â Âåëèêîáðèòàíèè ìåäèöèíñêàÿ è ñòðàõîâàÿ îáùåñòâåííîñòü âåñüìà îçàáî÷åíà òåì, ÷òî ê äàííîé ïðîöåäóðå ÷àñòî ïðèáåãàþò ïðîñòî èç-çà åå êàæóùåéñÿ ïðîñòîòû è ÷àñòî ïðèçðà÷íîé âûñîêîé ýôôåêòèâíîñòè. Íî Âû òî íàâåðíîå çíàåòå, ÷òî êàê ãîâîðÿò àìåðèêàíöû take home baby rate ïîñëå ICSI íå ïðåâûøàåò 20%. È êàêîâî æå òóò ñîîòíîøåíèå öåíû è ðåçóëüòàòà, îñîáåííî êîãäà åñòü è äðóãîé âïîëíå îáîñíîâàííûé ïóòü?



    Îòâå÷ó íà Âàø âîïðîñ. Madgar et al., 1995 (Fertil. Steril., 63: 120-124) ïîêàçàëè â ïðîñïåêòèâíîì ðàíäîìèçèðîâàííîì è êîíòðîëèðóåìîì èññëåäîâàíèè, ÷òî â ãðóïïå íåîïåðèðîâàííûõ ìóæ÷èí ñ âàðèêîöåëå áåðåìåííîñòü íàñòóïàëà ó èõ ïàðòíåðø òîëüêî â 10% ñëó÷àåâ ïðè 12 ìåñÿ÷íîì íàáëþäåíèè, â òî âðåìÿ êàê ó îïåðèðîâàííûõ â 67% è ïîçäíåå ïðè íàáëþäåíèè ïðîäîëæèòåëüíîñòüþ 36 ìåñÿöåâ â 76% ñëó÷àåâ. Íàäåþñü, ÷òî òåïåðü Âàì âñå ïîíÿòíî.



    Óêàçàííûå ôàêòû ïîçâîëÿþò ìíå ðåêîìåíäîâàòü ICSI òåì ïàðàì ñ ìóæñêèì ôàêòîðîì èíôåðòèëüíîñòè, â êîòîðûõ ó ìóæ÷èíû íå ïðåäñòàâëÿåòñÿ âîçìîæíûì âûÿâèòü è ñëåäîâàòåëüíî óñòðàíèòü êîððåãèðóåìóþ ïðè÷èíó. Íó à åñëè èìååòñÿ è íàéäåí êîððåãèðóåìûé ôàêòîð - åãî íàäî óñòðàíèòü. Îïðîâåðãíóòü òàêîé ïîäõîä ìîæíî òîëüêî ñðàâíèâ ðåçóëüòàòû âûïîëíåíèÿ ICSI òàêèì ïàðàì è ðåçóëüòàòû òåõ, ó êîãî ìóæ÷èíû ïîäâåðãëèñü ëå÷åíèþ. Åñòü ëè ó Âàñ òàêèå äàííûå? Íó à ðàññóæäåíèÿ ïî ïîâîäó òîãî, ÷òî ïðè äëèòåëüíîì ñåìåéíîì áåñïëîäèè îáÿçàòåëüíî ÷òî òî íå â ïîðÿäêå è ñ æåíùèíîé íîñÿò ÷èñòî àáñòðàêòíûé õàðàêòåð. Ýòî äîëæíî áûòü ïî âîçìîæíîñòè äîêàçàíî â êàæäîì êîíêðåòíîì ñëó÷àå.



    Ïî ïîâîäó èíôîðìèðîâàííîãî ñîãëàñèÿ ïàöèåíòêè ÿ ñ Âàìè ñîëèäàðåí. Íî èíôîðìàöèÿ, êîòîðóþ íàøè ïàöèåíòû ïîëó÷àþò âñå æå äîëæíà íîñèòü ìàêñèìàëüíî îáúåêòèâíûé õàðàêòåð áåç íàëåòà íàøåé óçêîñïåöèàëüíîñòè è äðóãèõ èíòåðåñîâ.

    Ñ óâàæåíèåì

  11. boris
    #11
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!



    Òåìà äåéñòâèòåëüíî âåñüìà äèñêóòàáåëüíà.

    Ñåé÷àñ ñêàæåì â Âåëèêîáðèòàíèè ìåäèöèíñêàÿ è ñòðàõîâàÿ îáùåñòâåííîñòü âåñüìà îçàáî÷åíà òåì, ÷òî ê äàííîé ïðîöåäóðå ÷àñòî ïðèáåãàþò ïðîñòî èç-çà åå êàæóùåéñÿ ïðîñòîòû è ÷àñòî ïðèçðà÷íîé âûñîêîé ýôôåêòèâíîñòè. Íî Âû òî íàâåðíîå çíàåòå, ÷òî êàê ãîâîðÿò àìåðèêàíöû take home baby rate ïîñëå ICSI íå ïðåâûøàåò 20%. È êàêîâî æå òóò ñîîòíîøåíèå öåíû è ðåçóëüòàòà, îñîáåííî êîãäà åñòü è äðóãîé âïîëíå îáîñíîâàííûé ïóòü?

    Ïðèâåäó ëèøü íåêîòîðûå öèôðû áåç êîììåíòàðèåâ. Ê ñîæàëåíèþ ýòè äàííûå îòíîñÿòñÿ ê 1999 â ñâÿçè ñ òåì, ÷òî îò÷åò ESRE (Euripean Society of Human Reproduction and Embryology) èçäàåòñÿ âñåãà ñ òðåõãîäè÷íûì îïîçäàíèåì (æåíùèíû äîëæíû çàáåðåìåíåòü âûíîñèòü è ðîäèòü ðåáåíêà è ãîä íà ñáîð èíôîðìàöèè). Ïðèâåäó ôðàãìåíò ýòîãî îò÷åòà (The European IVF-monitoring programme (EIM)*, for the European Society of Human Reproduction and Embryology (ESHRE) 1,2)

    Table VII. Pregnancies and deliveries after ICSI.



    Pregnancies

    per transfer / Lost to follow-up

    Greece 35,2% 4,3%

    Sweden 33,2% 0,0%

    Spain 32,5% 2,8%

    Poland 30,3% 0,0%

    Iceland 29,4% 0,0%

    Denmark 29,1% 4,3%

    Czech republiñ 28,8% 4,3%

    Norway 28,8% 0,9%

    Italy 28,6% 6,4%

    Finland 28,2% 0,1%

    Belgium 27,7% NA

    Netherlands 27,6% NA

    Germany 26,9% 6,2%

    France 26,3% 12,8%

    Portugal 25,8% 8,2%

    Ireland 25,2% 1,9%

    Switzerland 25,0% 35,9%

    Russia 23,5% NA

    Slovenia 22,7% 28,0%

    Hungary 22,1% 1,9%

    Ukraine 18,5% NA

    United Kingdom* NA NA





    * äàííûå òîëüêî ïî êîëè÷åñòâó ïðîâåäåííûõ öèêëîâ ICSI, äàííûå ïî íàñòóïëåíèþ áåðåìåííîñòè è ðîäàì íå ïðèâåäåíû.



    Êàê Âû âèäèòå öèôðû ïî ðåçóëüòàòèâíîñòè ýòîãî ìåòîäà ðàçëè÷íû äàæå ïî ñòðàíàì, îäíàêî ïîòåðè íå òàê âåëèêè êàê â Áðèòàíèè /âîçìîæíî Âû ïîëüçîâàëèñü ðåçóëüòàòàìè îäíîãî èç öåíòðîâ ïðåäîñòàâëÿâøèõ ñâîè äàííûå â íàöèîíàëüíûé ðåãèñòð è ïîýòîìó îíè îòëè÷íû îò âûøåïðèâåäåííûõ/:

    ×àñòîòà íàñòóïëåíèÿ áåðåìåííîñòè ïîñëå ïðîâåäåíèÿ ICSI êîëåáëåòñÿ â ïðåäåëàõ 18,5 – 35,2 % (â ñðåäíåì 27,9%) , ïîòåðè âî âðåìÿ áåðåìåííîñòè îò 0 äî 36 (â ñðåäíåì 6,9%)

    Åùå ðàç ïîä÷åðêèâàþ, ÷òî ýòî äàííûå òðåõãîäè÷íîé äàâíîñòè è â íàñòîÿùåå âðåìÿ îíè áîëåå îïòèìèñòè÷íû.

    Äàííûå ïî Ðîññèè òàêæå äàëåêî íå îäíîçíà÷íû.  ñèëó ðÿäà ïðè÷èí ÿ íå ìîãó ïðèâåñòè äàííûå ïî êîíêðåòíûì öåíòðàì â Ðîññèè, îäíàêî ïðèâåñòè äàííûå íàøåãî öåíòðà ÿ ìîãó.  2001 ãîäó ÷àñòîòà íàñòóïëåíèÿ áåðåìåííîñòè â ÌÖÐÌ (ÑÏá) ïîñëå ÈÊÑÈ ñîñòàâèëà 46%, ÷àñòîòà íåâûíàøèâàíèÿ â ýòîé ãðóïïå íå ïðåâûñèëà 11 %. (äàííûå ïðåäîñòàâëåííûå äëÿ Íàöèîíàëüíîãî îò÷åòà ïî ÂÐÒ, 2000)



    Madgar et al., 1995 (Fertil. Steril., 63: 120-124) ïîêàçàëè â ïðîñïåêòèâíîì ðàíäîìèçèðîâàííîì è êîíòðîëèðóåìîì èññëåäîâàíèè, ÷òî â ãðóïïå íåîïåðèðîâàííûõ ìóæ÷èí ñ âàðèêîöåëå áåðåìåííîñòü íàñòóïàëà ó èõ ïàðòíåðø òîëüêî â 10% ñëó÷àåâ ïðè 12 ìåñÿ÷íîì íàáëþäåíèè, â òî âðåìÿ êàê ó îïåðèðîâàííûõ â 67% è ïîçäíåå ïðè íàáëþäåíèè ïðîäîëæèòåëüíîñòüþ 36 ìåñÿöåâ â 76% ñëó÷àåâ. Íàäåþñü, ÷òî òåïåðü Âàì âñå ïîíÿòíî.

    Äåéñòâèòåëüíî òàêèå äàííûå ñóùåñòâóþò, îäíàêî ó÷èòûâàÿ òîò ôàêò, ÷òî óçêàÿ ñïåöèàëèçàöèÿ, êàê íè ñòàðàéñÿ, íîñèò òàê èëè èíà÷å ïðåäâçÿòûé õàðàêòåð, è ïûòàÿñü, ïî âîçìîæíîñòè, ïðåäñòàâèòü äëÿ ïàöèåíòà îáúåêòèâíóþ èíôîðìàöèþ, ÿ õîòåë áû ïðèâåñòè áîëåå ñâåæèå äàííûå (1998 ã.) èç ìîíîãðàôèè èçäàííîé â Ëîíäîíå ïîä ðåäàêöèåé Êóêà, ãäå â ãëàâå ïîñâÿùåííîé âàðèêîöåëå Ever G.L. ïîäâîäÿ èòîãè ìåòà-àíàëèçà ïÿòè ïðîñïåêòèâíûõ èññëåäîâàíèé, íàðÿäó ñî çíà÷èòåëüíûìè ïîçèòèâíûìè èçìåíåíèÿìè â êà÷åñòâå ñïåðìîãðàììû ó ìóæ÷èí ïåðåíåñøèõ îïåðàòèâíîå âìåøàòåëüñòâî íå íàõîäèò óâåëè÷åíèÿ ÷àñòîòû íàñòóïëåíèÿ áåðåìåííîñòè â áåñïëîäíîì áðàêå ó ýòîé ãðóïïû ïàöèåíòîâ , ïî ñðàâíåíèþ ñ íåîïåðèðîâàííûìè.

    Ó÷èòûâàÿ èìåííî, âîçìîæíî, óçêîñïåöèàëüíûé âçãëÿä íà ïðîáëåìó ðåïðîäóêòîëîãîâ íà âîïðîñû ñâÿçàííûå ñ ðåïðîäóêòèâíûì çäîðîâüåì ìóæ÷èí, íàø öåíòð ïðèâëåêàåò ñïåöèàëèñòîâ-óðîëîãîâ, êîòîðûå îêàçûâàþò êîíñóëüòàòèâíóþ è ëå÷åáíóþ ïîìîùü, îáðàòèâøèìñÿ ê íàì ïàöèåíòàì-ìóæ÷èíàì.



    Ïîëàãàþ, ÷òî êàæäûé èç íàñ, ïîëàãàÿñü íå òîëüêî íà ëèòåðàòóðíûå äàííûå, íî è íà ñîáñòâåííûé îïûò âíîñèò îáùèé âêëàä â îäíî äåëî – ëå÷åíèå áåñïëîäèÿ.

  12. Zhivov
    #12
    ×èòàòåëü Íåäóã.Ðó
    Äà, Áîðèñ Àëåêñàíäðîâè÷. Ìû âíîñèì ñâîé âêëàä êàæäûé ïî-ñâîåìó Ó ìåíÿ áûë ïàöèåíò ñ âàðèêîöåëå ó êîòîðîãî äî îïåðàöèè 2 ïîïûòêè ICSI â Âàøåì î÷åíü óâàæàåìîì ìíîþ öåíòðå çàêîí÷èëèñü íåóäà÷åé (ó íåãî áûëà îëèãî- è àñòåíîçîîñïåðìèÿ, ó æåíû òîæå áûëè êàêèå-òî ïðîáëåìû), áåðåìåííîñòü íå íàñòóïàëà. Ïîñëå îïåðàöèè ÷åðåç 3 ìåñÿöà ïðè î÷åðåäíîì öèêëå ICSI áåðåìåííîñòü íàñòóïèëà è æåíà ðîäèëà çäîðîâîãî ðåáåíêà. Îäèí ñëó÷àé åñòåñòâåííî íå ïîêàçàòåëü, íî òàê ÷òî òî âñïîìíèëîñü.



    ß áû ïîïðîñèë Âàñ ïðèâåñòè òî÷íûå äàííûå ïî öèòèðîâàííîé Âàìè "ìîíîãðàôèè èçäàííîé â Ëîíäîíå ïîä ðåäàêöèåé Êóêà".  äîñòóïíîé ìíå ëèòåðàòóðå ÿ íå âñòðå÷àë èíôîðìàöèè î òîì, ÷òî âàðèêîöåëýêòîìèÿ íå âëèÿåò ïîçèòèâíî íà óâåëè÷åíèå ÷àñòîòû áåðåìåííîñòåé áåñïëîäíûõ ïàð. Ñïàñèáî.

  13. Zhivov
    #13
    ×èòàòåëü Íåäóã.Ðó
    Õîòÿ äàííîå èñëåäîâàíèå ïîõîæå íå áûëî ðàíäîìèçèðîâàííûì, ÿ âñå æå ïîçâîëþ ñåáå åãî ïðèâåñòè êàê äîñòàòî÷íî ñâåæåå.



    Int J Urol 2002 Aug;9(8):455-61



    Clinical study of varicocele: Statistical analysis and the results of long-term follow-up.



    Onozawa M, Endo F, Suetomi T, Takeshima H, Akaza H.



    Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba City, Japan.



    BACKGROUND: The results of clinical examinations of varicocele and the clinical outcome of varicocelectomy conducted at Tsukuba University Hospital, Tsukuba City, Japan were analyzed. METHODS: The subjects of the present study were sixty-four infertile male patients with varicocele who visited our hospital from 1991to 1999. A physical examination, semen analysis and hormonal evaluation were performed for each patient. Patients selected their preferred type of treatment (varicocelectomy or conservative treatment) after providing their informed

    consent. RESULTS: The age of the patients was 34.1 +/- 5.1(mean +/- standard deviation [s.d.]) years, and the infertile duration was 4.2 +/- 3.0 (mean +/- s.d.) years. Fifty-one cases were left-sided; 13 were bilateral. Mean sperm density ( yen 106/mL) was 37.2 for Grade I, 21.3 for Grade II and 9.4 for Grade

    III. Sperm density was significantly lower in the higher-graded patients (P = 0.008). Varicocelectomy was performed in 31 cases; the postoperative/preoperative ratio of sperm density was significantly higher in the higher-graded varicocele (P = 0.04), and the peak/base ratio of follicle-stimulating hormone (FSH) after luteinizing hormone-releasing hormone (LH-RH) stimulation was significantly decreased after varicocelectomy (P = 0.007). The pregnancy rate in the partners of the varicocelectomized group (60%) was significantly higher than in the conservatively treated group (28%) P = 0.04; the mean follow-up duration was 76.2 months. CONCLUSION: These results show that varicocele should influence spermatogenesis, therefore altered spermatogenesis could be effectively treated by varicocelectomy, and varicocelectomy should induce a higher probability of pregnancy.



    Åùå îäíî èññëåäîâàíèå îïÿòü æå ê ñîæàëåíèþ ðåòðîñïåêòèâíîå. îäíàêî äîñòàòî÷íî óáåäèòåëüíîå.



    Fertil Steril 2001 May;75(5):1013-6



    Microsurgical varicocelectomy in the era of assisted reproductive technology: influence of initial semen quality on pregnancy rates.



    Kamal KM, Jarvi K, Zini A.



    Division of Urology, Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.



    OBJECTIVE: To evaluate the natural history of infertile couples in whom the man underwent varicocelectomy. DESIGN: Retrospective study. SETTING: University infertility clinic. PATIENT(S): 159 infertile couples. INTERVENTION(S): Microsurgical varicocelectomy. MAIN OUTCOME MEASURE(S): Standard semen

    parameters and pregnancy rates (assisted and unassisted). RESULT(S): Postoperative sperm concentration and motility increased significantly compared to before the varicocelectomy (28.9 +/- 3.0 vs. 22.5 +/- 2.1 x 10(6)/mL and 33.9 +/- 1.9 vs. 22.1 +/- 1.3%, respectively). Overall, 48% (76/159) of the couples

    achieved a spontaneous pregnancy at the mean of 30 months' follow-up. An additional 10% (16/159) and 11% (18/159) of couples achieved a pregnancy following intrauterine insemination and in vitro fertilization/intracytoplasmic sperm injection, respectively. Significantly higher spontaneous pregnancy rates

    were observed in couples in whom the man's initial sperm concentration was greater than or equal to 5 million sperm per milliliter compared to those in whom the man's initial sperm concentration was less than 5 million sperm per milliliter (61% vs. 8%, respectively). CONCLUSION(S): Our data demonstrate that,

    in couples in whom the man undergoes varicocelectomy for treatment of varicocele, close to 70% achieve a pregnancy. The initial sperm concentration is predictive of unassisted pregnancy outcome in this population.



    ß åùå ðàç õî÷ó ïîä÷åðíóòü, ÷òíî íè â ëèòåðàòóðå (Medline search è ìí. äð.) íè ïî äàííûì ìîèõ îáøèðíûõ ëè÷íûõ êîíòàêòîâ è ïîñëåäíèõ ñúåçäîâ è ñèìïîçèóìîâ ïî òåìå ÿ íèêîãäà íå âñòðå÷àë èíôîðìàöèè î òîì, ÷òî âàðèêîöåëýêòîìèÿ íå âëèÿåò íà óâåëè÷åíèå ÷àñòîòû áåðåìåííîñòåé â áåñïëîäíûõ ïàðàõ. Åùå ðàç, Áîðèñ Àëåêñàíäðîâè÷, óáåäèòåëüíî ïðîøó Âàñ óêàçàòü ìíå èñòî÷íèê, îòêóäà áûëà âçÿòà Âàøà èíôîðìàöèÿ.

  14. Zhivov
    #14
    ×èòàòåëü Íåäóã.Ðó
    Ó Âàñ âîçíèêëè ïðîáëåìû ñ ïîèñêîì ññûëêè, Áîðèñ Àëåêñàíäðîâè÷?

  15. boris
    #15
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!

    Ïðèíîøó ñâîè èçâèíåíèÿ çà âûíóæäåííóþ ïàóçó.

    Ó Âàñ âîçíèêëè ïðîáëåìû ñ ïîèñêîì ññûëêè, Áîðèñ Àëåêñàíäðîâè÷?

    Ïðîáëåìû äåéñòâèòåëüíî áûëè, ò.ê. ïðåæäå ÷åì âñòóïàòü ñ Âàìè â äèñêóññèþ ïî óçêîñïåöèôè÷íîìó âîïðîñó, êîòîðûì ÿ íå âëàäåþ â ïîëíîì îáúåìå, ÿ íå ñòàë ïîëüçîâàòüñÿ èíôîðìàöèîííûìè óñëóãàìè îáåñïîêîåííîé ìåäèöèíñêîé è ñòðàõîâîé îáùåñòâåííîñòè Âåëèêîáðèòàíèè, íå èñïîëüçîâàë â êà÷åñòâå áèáëèîãðàôè÷åñêèõ èñòî÷íèêîâ ìíåíèå íåêèõ àìåðèêàíöåâ (”êàê ãîâîðÿò àìåðèêàíöû take home baby rate ïîñëå ICSI íå ïðåâûøàåò 20%”), à ïðîêîíñóëüòèðîâàëñÿ ó ñïåöèàëèñòîâ-óðîëîãîâ, êîòîðûå, êñòàòè êàê è Âû èìåþò âåñüìà íåîäíîçíà÷íîå ìíåíèå ïî ýòîìó âîïðîñó, íî âñå æå íå ñòîëü êàòåãîðè÷íû. Èìåííî ïîýòîìó ïîñëå îáùåíèÿ ïî òåëåôîíó ñ êîëëåãàìè, ÿ ïîïðîñèë ïîñìîòðåòü äàííûå ïî ýòîìó âîïðîñó è ïðîêîììåíòèðîâàòü Âàøå âûñêàçûâàíèå.

    Åñòåñòâåííî, ÿ íå ìîã ïðåäïîëîæèòü, ÷òî ïîñëå òîãî êàê ÿ ïðèâåë, ïóñòü äàæå íåïîëíûå äàííûå èñòî÷íèêà (ò.ê. íå çàïèñàë òî÷íûå ), ó Âàñ, êàê ó ñïåöèàëèñòà, åæåäíåâíî çàíèìàþùåãîñÿ àíäðîëîãèåé, ïîÿâÿòñÿ ïðîáëåìû ñ óòî÷íåíèåì èñòî÷íèêà èíôîðìàöèè. (ÿ íàäåþñü, ÷òî Âû íå çàïîäîçðèëè ìåíÿ â ôàëüñèôèêàöèè äàííûõ).  ìîìåíò ðàçãàðà äèñêóññèè ìîé êîëëåãà-óðîëîã, íàõîäèëñÿ íà îäíîì èç àíäðîëîãè÷åñêèõ ôîðóìîâ, ñ ÷åì è áûëî ñâÿçàíî ìîå âðåìåííîå ìîë÷àíèå.



    ß áû ïîïðîñèë Âàñ ïðèâåñòè òî÷íûå äàííûå ïî öèòèðîâàííîé Âàìè "ìîíîãðàôèè èçäàííîé â Ëîíäîíå ïîä ðåäàêöèåé Êóêà".  äîñòóïíîé ìíå ëèòåðàòóðå ÿ íå âñòðå÷àë èíôîðìàöèè î òîì, ÷òî âàðèêîöåëýêòîìèÿ íå âëèÿåò ïîçèòèâíî íà óâåëè÷åíèå ÷àñòîòû áåðåìåííîñòåé áåñïëîäíûõ ïàð.

    Íå òîëüêî ïðèâîæó, íî è öèòèðóþ (ê ñîæàëåíèþ ñàìîé ìîíîãðàôèåé ÿ íå âëàäåþ, ïîýòîìó íå ìîãó åå Âàì ïåðåäàòü äëÿ îçíàêîìëåíèÿ):

    5 ïðîñïåêòèâíûõ ðàíäîìèçèðîâàííûõ èññëåäîâàíèé ëå÷åíèÿ âàðèêîöåëå ó âçðîñëûõ ïðèâåëè ê ïðîòèâîðå÷èâûì âûâîäàì. Íàèáîëüøåå èç íèõ ñâèäåòåëüñòâóåò îá ýôôåêòèâíîñòè ëå÷åíèÿ (Madgar I et al., 1995), îöåíèâàåìîé ïî ÷àñòîòå íàñòóïëåíèÿ áåðåìåííîñòè è ñîîòíîøåíèþ áåðåìåííîñòü/öèêë. Îäíàêî, ìåòà-àíàëèç 5 èññëåäîâàíèé, âûïîëíåííûé ïîçäíåå, óêàçàë íà îòñóòñòâèå ïðåèìóùåñòâ ëå÷åíèÿ âàðèêîöåëå (Evers J.L. â êíèãå Templeton, Cooke (eds) Evidence based fertility treatment, London, 1998).



    Âîçìîæíî ÿâëÿÿñü ÷ëåíîì Àìåðèêàíñêîé Óðîëîãè÷åñêîé Àññîöèàöèè è Àìåðèêàíñêîãî Îáùåñòâà ïî èçó÷åíèþ èìïîòåíöèè, Âû íå ñòîëü âíèìàòåëüíî îòíîñèòåñü ê åâðîïåéñêèì êîëëåãàì:

    Ñîãëàñíî ðåêîìåíäàöèÿì Åâðîïåéñêîé Àññîöèàöèè Óðîëîãîâ (2002): "Ïîêàçàíèÿ ê ëå÷åíèþ âàðèêîöåëå â áåñïëîäíûõ áðàêàõ îñòàþòñÿ ïðîòèâîðå÷èâûìè è â íàñòîÿùåå âðåìÿ ÿâëÿþòñÿ ïðåäìåòîì êðèòèêè. Òðåáóþòñÿ äàëüíåéøèå èññëåäîâàíèÿ, êîòîðûå ïðîâîäÿòñÿ â íàñòîÿùèé ìîìåíò (Paduch DA, 1997). Ëå÷åíèå íå äîëæíî áûòü ïðîâåäåíî äî òåõ ïîð, ïîêà ñ ïàöèåíòîì íå áóäåò ïðîâåäåíà ïîëíîöåííàÿ áåñåäà î íåîïðåäåëåííîñòè ðåçóëüòàòîâ".



    ß åùå ðàç õî÷ó ïîä÷åðíóòü, ÷òíî íè â ëèòåðàòóðå (Medline search è ìí. äð.) íè ïî äàííûì ìîèõ îáøèðíûõ ëè÷íûõ êîíòàêòîâ è ïîñëåäíèõ ñúåçäîâ è ñèìïîçèóìîâ ïî òåìå ÿ íèêîãäà íå âñòðå÷àë èíôîðìàöèè î òîì, ÷òî âàðèêîöåëýêòîìèÿ íå âëèÿåò íà óâåëè÷åíèå ÷àñòîòû áåðåìåííîñòåé â áåñïëîäíûõ ïàðàõ.



    Âû çíàåòå, Àëåêñåé Âèêòîðîâè÷, ÿ òîæå áåçóñïåøíî ïûòàëñÿ íàéòè â Medline ññûëêè íà ðóêîâîäñòâî Ivf Ýäâàðäñà “ R. Edwards. A textbook of In-Vitro Fertilization and Assisted Reproduction. Edited by Peter R. Brinsden. Second edition. 1999” êîòîðîå äëÿ íàñ ÿâëÿåòñÿ “íàñòîëüíîé êíèãîé”, íî óâû! Èíòåðíåò äåéñòâèòåëüíî â íàñòîÿùåå âðåìÿ ïðåäîñòàâëÿåò áîëüøèå âîçìîæíîñòè â ïîèñêå èíôîðìàöèè, íî êàê âû ïîíèìàåòå, îòíþäü, ýòî íå êàñàåòñÿ ìîíîãðàôèé, êîòîðûå êàê è ïðåæäå ïðåäëàãàþò òîëüêî ïîñëå ïåðåâîäà îïðåäåëåííîé ñóììû.

    Ïîýòîìó, åñëè Âàñ è âïðåäü áóäóò èíòåðåñîâàòü îôèöèàëüíûå äàííûå îòíîñèòåëüíî âñïîìîãàòåëüíîé ðåïðîäóêöèè, ÿ áóäó ðàä Âàì ïîìî÷ü. Êñòàòè ñïàñèáî çà ïðèâåäåííûå ñòàòüè ïî ëå÷åíèþ âàðèêîöåëå. Íàäåþñü è Âû íå îòêàæåòå ìíå â ïîäîáíîé ïîìîùè.



    Ñ óâàæåíèåì

    Á.Êàìåíåöêèé



    PS: Ìîè ðåïëèêè îòíîñèòåëüíî îáåñïîêîåííîé áðèòàíñêîé îáùåñòâåííîñòè, àìåðèêàíöåâ è 20% íå îáÿçûâàþò Âàñ èñêàòü áèáëèîãðàôè÷åñêèå ññûëêè. Íàñêîëüêî ÿ ïîíèìàþ ýòè äàííûå áûëè ïîëó÷åíû íå èç íàó÷íûõ æóðíàëîâ.

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •